Ireland
--:--IST
Latest
Clinical Trials in Sweden / NCT06979050
Active, not recruiting Not applicable

Evaluation of the Ronnie Gardiner Method in Individuals With Stroke in Late Phase of Recovery

NCT06979050 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2025-07-21
Last updated
2025-10-03

Condition(s) studied

Stroke

Investigational drug(s) / intervention(s)

The Ronnie Gardiner Method

The Ronnie Gardiner Method: The intervention involves participants performing coordinated movements while saying specific cue words, synchronized to rhythmic music. The exercises are guided by a visual notation system consisting of 19 colored symbols that represent different body parts and movements. Red symbols indicate movements on the left side of the body, while blue symbols represent the right side. Each symbol corresponds to a specific movement and verbal cue. Exercises are typically performed standing to maximize balance effects and are accompanied by rhythmic, often popular, music to enhance engagement and motivation. Complexity can be increased by adjusting the tempo of the music or combining multiple symbols. Training sessions are conducted in groups, led by certified instructors, twice per week for 12 weeks (60 minutes per session), with an additional home-based practice session each week.

Study summary

Stroke is a common condition that often leads to long-term disabilities, significantly affecting individuals' quality of life and imposing substantial societal costs. There is growing evidence that physical rehabilitation can improve motor function, well-being, and quality of life even in the chronic phase after stroke. In recent years, rhythm- and music-based interventions have gained increasing attention as promising tools in neurorehabilitation. The Ronnie Gardiner Method (RGM) is a structured, music-based training method that engages motor, sensory, cognitive, and emotional functions simultaneously. While preliminary studies have shown positive effects of RGM in individuals with Parkinson's disease, there is limited research on its impact in stroke rehabilitation, particularly in the chronic phase.

This randomized controlled multicenter study aims to evaluate the effects of RGM training in individuals aged 18 and older who are more than six months post-stroke. Participants will be randomly assigned to either an intervention group receiving RGM training twice per week for 12 weeks, or to a passive control group. The primary outcome is balance, assessed by the Mini-BESTest. Secondary outcomes include gait, upper limb function, cognitive abilities such as working memory and divided attention, and health-related quality of life. Additionally, qualitative data will be collected to explore participants' and trainers' experiences regarding motivation, engagement, and perceived impact on daily participation. The study is expected to provide valuable evidence on the clinical usefulness of RGM in chronic stroke rehabilitation and its potential to be implemented as part of community-based, cost-effective rehabilitation programs.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Community-dwelling individuals with stroke that occurred \> 6 months ago * Cognitive ability corresponding to at least 25 out of 30 points on the Montreal Cognitive Assessment (MoCA) * Functional disability corresponding to a Modified Rankin Scale (mRS) score of 2-3 * No assistance required for daily activities during participation (e.g., can independently travel to measurement/training sites and use the restroom) * Ability to stand for 2 minutes without support and walk 10 meters with or without assistive devices, but without supervision Exclusion Criteria: * Severe visual and/or hearing impairments that would interfere with study participation * Participation in regular sessions with RGM after August 2024 * Previous experience playing a musical instrument (defined as practicing \>1 hour/week in the past 10 years) * A score of less than 25 on the Montreal Cognitive Assessment (MoCA)

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Folkuniversitetet Gothenburg Sweden
Resurscentrum Karlstad Sweden
Neurologiska rehabiliteringskliniken Stockholm Sweden

More Göteborg University trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06979050 on ClinicalTrials.gov ↗ ← All trials in Sweden